Recent studies have shown that genetic depletion or chemical inhibition of SHP-1 enhances AML differentiation and compromise leukemogenesis through STAT6-Itgb3 (encode CD61) axis47,48. Here, ITGB3 is linked to acute myeloid leukemia.